Results 231 to 240 of about 5,219,314 (384)
This study aimed to investigate the safety and efficacy of pelvic reinforcement procedure (PRP) in robotic abdominoperineal resection (Ro‐APR). PRP‐ had a significantly higher rate of imaged perineal hernia (PH) (39.2% vs. 6.7%, p = 0.005) and symptomatic PH (19.6% vs.
Yoshihiro Sakai+8 more
wiley +1 more source
Deep learning‐based prediction model for operative mortality using the National Clinical Database (NCD). The model achieved a C‐statistic of 0.74. ABSTRACT Background Radical gastrectomy with lymph node dissection is the primary treatment for gastric cancer.
Ryosuke Fukuyo+5 more
wiley +1 more source
This study showed that the pancreaticogastrostomy technique in HPD of biliary tract cancer reduced the incidence of pancreatic fistula from 45% to 12%. In‐hospital mortality was also reduced from 27% to 3%. ABSTRACT Background and Purpose Although hepatopancreaticoduodenectomy (HPD) is effective for margin‐negative curative resection of biliary tract ...
Ryusei Matsuyama+9 more
wiley +1 more source
This prospective study investigated the impact of MIS on frailty and outcomes in elderly CRC patients. While frail patients showed lower OS, MIS was safely performed. Among recurrence‐free patients, frailty status improved at 1 year, suggesting that curative surgery may offer not only oncologic benefits but also potential for frailty improvement ...
Hajime Ushigome+9 more
wiley +1 more source
Background: Preoperative competence is a crucial aspect of nursing student’s education for improving the quality of care and patient safety.
Mohammad Etoom, Rafi Alnjadat
doaj
ABSTRACT Background Large type III gastric cancer (GC) ≥ 8 cm has conventionally been categorized with type IV GC in Japan, leading to alternative treatment strategies such as neoadjuvant chemotherapy and staging laparoscopy (SL). However, whether 8 cm is the correct cutoff remains unclear.
Yutaka Sugita+8 more
wiley +1 more source
Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer
ABSTRACT Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile ...
Osamu Itano, Takuya Minagawa
wiley +1 more source